-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results

Dow Jones·11/16/2026 12:00:00

Please log in to view news